René Raepple

ZOLL CMS GmbH develops and manufactures the lifevest wearable defibrillator, a proven therapy for patients at risk of sudden cardiac death. ZOLL CMS is based in Cologne, DE. The device allows patients to return to most of their daily activities with peace of mind that they have protection. The German company offers education programs regarding wearable cardioverter defibrillators and provides extensive clinical evidence that supports the wearable cardioverter defibrillator (WCD) as a therapy for protection from sudden cardiac death (SCD). The CEOs of the private company are Jason T. Whiting, René Raepple, Christoph Stöppler.